Zhuhai Shutong develops gene editing and molecular diagnostic products and services.
Founded in 2019 and based in Zhuhai, Zhuhai Shutong develops products for tumor screening, companion diagnostics, genetic disease diagnostics, and pathogen detection. Its platforms cover gene editing, molecular diagnostics, and sgRNA design and off-target prediction. In September 2023, it raised Series A funding led by Shanxi Growth Enterprise Leading Fund, with participation from Guangdong Technology Financial Group, Kaikai Venture Capital, and Huanuo Medical Fund.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign inWork at Zhuhai Shutong Medical Technology? This is my company